This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations of Andrew Lewis Theophilus
Introduction
Andrew Lewis Theophilus is a notable inventor based in Ware, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on crystalline complexes.
Latest Patents
One of his key patents is titled "Crystalline complexes of fluticasone-2-furoate." This patent describes a crystalline complex that comprises a compound of formula (I), where the crystal lattice is stabilized by the presence of a guest molecule. The crystalline complex is characterized by being of space group P222, with unit cell dimensions of about 12.5±1.0 Å, 15±1.0 Å, and 16.2±1.0 Å when determined at either 120K or 150K. This innovation has the potential to enhance the efficacy of pharmaceutical formulations.
Career Highlights
Andrew Lewis Theophilus is associated with Glaxo Group Limited, a leading company in the pharmaceutical industry. His work has contributed to advancements in drug formulation and delivery systems.
Collaborations
He has collaborated with notable coworkers, including Keith Biggadike and Steven John Coote, who have also made significant contributions to the field.
Conclusion
Andrew Lewis Theophilus is a distinguished inventor whose work on crystalline complexes has the potential to impact the pharmaceutical industry significantly. His innovative approach continues to pave the way for advancements in drug formulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile